Emerging NASH Treatments
Emerging NASH Treatments

Released: July 01, 2020

Expiration: June 30, 2021

Philip N. Newsome
Philip N. Newsome, PhD, FRCPE

Activity

Progress
1
Course Completed

Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis, including those in phase III such as:

  • Obeticholic acid
  • Cenicriviroc
  • Resmetirom
  • Aramchol

Download the slides from this podcast at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics/emerging-treatment-approaches/slides

See more NASH topics at: https://www.clinicaloptions.com/internal-medicine/programs/2019-nash-hot-topics